Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 37 min ago
Peer-reviewedLicence not statedNeurology

Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients with Frontotemporal Lobar Degeneration

  • Rogan Magee1,2
  • Sharon X. Xie2
  • Daniel T. Ohm1,3
  • Emma Rhodes3
  • Lauren Massimo3
  • Vivianna van Deerlin3
  • David A. Wolk4
  • Edward B. Lee4,5,6
  • Corey T. McMillan3,4
  • David J. Irwin1,3
6 affiliations
  1. 1Penn Digital Neuropathology Lab, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  2. 2Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA
  3. 3Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
  4. 4Alzheimer’s Disease Research Center Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
  5. 5Center for Neurodegenerative Disease Research, Department of Pathology & Laboratory Medicine University of Pennsylvania, Philadelphia, PA, USA
  6. 6Translational Neuropathology Lab, Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
Read full textDOICite

Related

  1. Neurotransmitter-defined cerebral vulnerability patterns in frontotemporal lobar degeneration (FTLD)
    Marlene Tahedl, Alison Toomey, Naser Mandal +9
    Journal of NeurologyPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthPMC
  2. Smartphone Passive Digital Phenotyping in Frontotemporal Lobar Degeneration
    E. W. Paolillo, S. Dhanam, J. C. Taylor +39
    medRxivPreprintCC BY-NC-NDFull textNeurologymedRxiv
  3. Plasma immune signatures associate with neurodegeneration in frontotemporal lobar degeneration
    M. van Schaik, K. O. Lai, N. L. Shapiro +14
    medRxivPreprintCC BYFull textNeurologymedRxiv
  4. Myo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degeneration
    S. Y. Tan, M. Naessens, P. S. Jones +12
    medRxivPreprintCC BYFull textNeurologymedRxiv
  5. Pretreatment Body Composition and Its Association with Pathologic Complete Response and Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Retrospective Cohort Study
    Erhan Tükel, Süleyman Özkan Aksoy, Ali İbrahim Sevinç +9
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{magee2026association,
  title = {{Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients with Frontotemporal Lobar Degeneration}},
  author = {Rogan Magee and Sharon X. Xie and Daniel T. Ohm and Emma Rhodes and Lauren Massimo and Vivianna van Deerlin and David A. Wolk and Edward B. Lee and Corey T. McMillan and David J. Irwin},
  journal = {Neurology},
  year = {2026},
  month = jul,
  doi = {10.1212/wnl.0000000000218278},
  url = {https://doi.org/10.1212/wnl.0000000000218278},
}
RIS
TY  - JOUR
TI  - Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients with Frontotemporal Lobar Degeneration
AU  - Rogan Magee
AU  - Sharon X. Xie
AU  - Daniel T. Ohm
AU  - Emma Rhodes
AU  - Lauren Massimo
AU  - Vivianna van Deerlin
AU  - David A. Wolk
AU  - Edward B. Lee
AU  - Corey T. McMillan
AU  - David J. Irwin
PY  - 2026
DA  - 2026/07/21
JO  - Neurology
DO  - 10.1212/wnl.0000000000218278
UR  - https://doi.org/10.1212/wnl.0000000000218278
SN  - 0028-3878
SN  - 1526-632X
ER  -